NEOS NEW BORN SOLUTIONS, S.L.

Newborn Solutions is a medical device start-up that will enable non-invasive screening, diagnosis, and monitoring of infections in serous body fluids, with an initial and focus on infant meningitis.
Meningitis suspicion is challenging due to the unspecific signs associated with the infection, such as fever of unknown source, particularly in infants and newborns with very little symptomatology. That is why history and physical examination alone are often insufficient to confirm or exclude the diagnosis. Lumbar puncture to draw a sample of cerebrospinal fluid is an essential investigation and the current standard, but it is often difficult to obtain a clean sample and potentially hazardous for the sick child. Neosonics, the medical device we have developed, will be used to accurately rule out or arise early suspicion of meningitis in a quick, easy and cost-effective way.
Neosonics is a first-in-class medical device that uses high-resolution ultrasound, unique coupling materials and deep learning artificial intelligence algorithms to automatically count, at the push of a button, white blood cells in the cerebrospinal fluid directly below the infant fontanelle, a well-established diagnostic marker for infections.
We are also developing second-line applications, upon request from key opinion leaders. Particularly, the device is being tested to show clinical proof of concept in uveitis and peritoneal dialysis. First data from these second-line applications are already very promising.
For the peritoneal dialysis application, the device will automatically count white blood cells present in the dialysis bag, improving early detection of infection and ultimately improving the patients well-being.
Uveitis can lead to blindness if not detected early. Our device will enable automatic and accurate white blood cell count in the anterior chamber of the eye and improve early detection and monitoring of patients.
This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.